NKINE

Welcome to the Brand page for “NKINE”, which is offered here for Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, cancer, autoimmune diseases, and infectious diseases for scientific, clinical, medicinal, and therapeutic purposes; pharmaceutical preparations and substances for the prevention of human diseases, animal diseases, cancer, autoimmune diseases, and infectious diseases; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases, animal diseases, cancer, autoimmune diseases, and infectious diseases; biological preparations for medical purposes, in the fields of immunotherapy, and immuno-oncology; anti-infectives for medical use for the treatment of human diseases, animal diseases, autoimmune diseases, and infectious diseases;medical services; medical information; providing a website featuring medical information in the fields of immunotherapy; providing a website featuring medical information in the fields of oncology, cancer, immune-oncology, autoimmune diseases, infectious diseases, human diseases, and animal diseases; providing information relating to pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases and animal diseases;medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases, animal diseases; product development in the fields of pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases and animal diseases;.

Its status is currently believed to be active. Its class is unavailable. “NKINE” is believed to be currently owned by “IMMUNITYBIO, INC.”